Episode 253: 253. EMPA-REG OUTCOME - Type 2 Diabetes and Empagliflozin- How Much Money To Save How Many People?
EMPA-REG OUTCOME back in 2015 this was the first SGLT2 trial to set the world on fire with Primary Outcome:
death from cardiovascular causes: NNT 46 per 3.1 yrs (at $600 a month, 1 million dollars per life saved)
nonfatal myocardial infarction: NS∞
nonfatal stroke: NS∞
https://www.nejm.org/doi/full/10.1056/nejmoa1504720